Juvenile Methylphenidate Exposure and Factors That Influence Incentive Processing
Open accessThe DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
Methylphenidate (MPH) is one of the few psychotropic agents approved for use in pediatric populations, underscoring the importance of elucidating any long-term consequences following exposure to this agent. Here, we examined the influence of several variables (i.e. age of assessment, age of exposure, sex, route of administration) on the effect of chronic low-dose MPH (2 mg/kg, twice daily) exposure on place conditioning to cocaine. Juvenile exposure to MPH, but not later exposure, resulted in aversions to cocaine-paired environments when assessed in young adult male rats, but not those entering adolescence. Juvenile MPH enhanced place preferences for cocaine-paired environments in female adolescent rats. The route of administration (i.p. injection or oral ingestion) did not produce enduring differential effects on behavior, and D-MPH was confirmed as the active enantiomer. These observations add to the growing literature on the enduring effects of MPH exposure, and highlight the need for more research in females.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pharmacotherapeutic interventions, such as pre-pubertal methylphenidate exposure, can reduce the rewarding properties of drugs later in life (Adriani et al., 2006a, Andersen et al., 2002a, Brenhouse et al., 2009, Carlezon et al., 2003, Thanos et al., 2007).”
From Sensitive periods of substance abuse: Early risk for the transition to dependence (2017) · cites this paper as Brenhouse et al., 2009
In the citing paper
“Preclinical research suggests that females experience different long-term effects following pre-pubertal (Brenhouse et al., 2009), pubertal, or even adult exposure to drugs (Dow-Edwards, 2010).”
From Sensitive periods of substance abuse: Early risk for the transition to dependence (2017) · cites this paper as Brenhouse et al., 2009
Citations
Cites
Johnston, L. D., O'Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2009) · PsycEXTRA Dataset · doi:10.1037/e560352009-001 · Cited by 6,921
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
Everitt, B. J., & Robbins, T. W. (2005) · Nature Neuroscience · doi:10.1038/nn1579 · Cited by 3,785 · cited 1×
“These processes are initiated by the Pavlovian conditioning of drug-related cues [”
BackgroundThe debate over dopamine’s role in reward: the case for incentive salience
Berridge, K. C. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0578-x · Cited by 2,347
Tzschentke, T. M. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00070.x · Cited by 1,336
Tzschentke, T. M. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00060-4 · Cited by 1,266
Becker, J. B., & Hu, M. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.07.003 · Cited by 1,003
Wilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003) · Pediatrics · doi:10.1542/peds.111.1.179 · Cited by 872
Regulation of cocaine reward by CREB
Carlezon, W. A., Thome, J., Olson, V. G., Lane-Ladd, S. B., Brodkin, E. S., Hiroi, N., Duman, R. S., Neve, R. L., & Nestler, E. J. (1998) · Science · doi:10.1126/science.282.5397.2272 · Cited by 767
Wagner, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00367-0 · Cited by 739 · cited 1×
“The risk of developing a significant drug addiction to psychostimulants is 4 times higher if use is initiated between 11 and 14 years of age than if initiated at any other age [”
BackgroundBerridge, C. W., Devilbiss, D. M., Andrzejewski, M. E., Arnsten, A. F. T., Kelley, A. E., Schmeichel, B., Hamilton, C., & Spencer, R. C. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.022 · Cited by 617
Kalivas, P., & Duffy, P. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-01-00266.1993 · Cited by 509
Everitt, B. J., Morris, K. A., O'Brien, A., & Robbins, T. W. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90145-e · Cited by 507
Pharmacotherapy of Attention-deficit/Hyperactivity Disorder Reduces Risk for Substance Use Disorder
Biederman, J., Wilens, T., Mick, E., Spencer, T., & Faraone, S. V. (1999) · Pediatrics · doi:10.1542/peds.104.2.e20 · Cited by 493
Sex differences in the acquisition of intravenously self-administered cocaine and heroin in rats
Lynch, W. J., & Carroll, M. E. (1999) · Psychopharmacology · doi:10.1007/s002130050979 · Cited by 463
Dextroamphetamine: Cognitive and Behavioral Effects in Normal Prepubertal Boys
Rapoport, J. L., Buchsbaum, M. S., Zahn, T. P., Weingartner, H., Ludlow, C., & Mikkelsen, E. J. (1978) · Science · doi:10.1126/science.341313 · Cited by 373 · cited 1×
“are arguably due to low availability and minimal euphoric effects [”
BackgroundNeuroplasticity Mediated by Altered Gene Expression
McClung, C. A., & Nestler, E. J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301544 · Cited by 347
Mueller, D., & Stewart, J. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00239-4 · Cited by 322
Sex differences in dopamine receptor overproduction and elimination
Andersen, S. L., Rutstein, M., Benzo, J. M., Hostetter, J. C., & Teicher, M. H. (1997) · NeuroReport · doi:10.1097/00001756-199704140-00034 · Cited by 316
Self-citationKuczenski, R., & Segal, D. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07264.2002 · Cited by 316 · cited 1×
“However, the self-administration paradigm, while considered one of the most ideal paradigms for drug assessment, is not ideal for developmental studies due to technical issues such as catheterization, patency issues, and long training sessions. Alternatively, behavioral plasticity is assessed by repeatedly exposing an…”
BackgroundMonitoring the future. Building an early warning system for the Dutch Ministry of Justice
Botterhuis, L., van der Duin, P., de Ruijter, P., & van Wijck, P. (2010) · Futures · doi:10.1016/j.futures.2009.11.030 · Cited by 290
FIXED‐INTERVAL SCHEDULE OF COCAINE REINFORCEMENT: EFFECT OF DOSE AND INFUSION DURATION1
Balster, R. L., & Schuster, C. R. (1973) · Journal of the Experimental Analysis of Behavior · doi:10.1901/jeab.1973.20-119 · Cited by 290
Brenhouse, H. C., Sonntag, K. C., & Andersen, S. L. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5064-07.2008 · Cited by 287
Self-citationBolaños, C. A., Barrot, M., Berton, O., Wallace-Black, D., & Nestler, E. J. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00570-5 · Cited by 268
Altered responsiveness to cocaine in rats exposed to methylphenidate during development
Andersen, S. L., Arvanitogiannis, A., Pliakas, A. M., LeBlanc, C., & Carlezon, W. A. (2002) · Nature Neuroscience · doi:10.1038/nn777 · Cited by 259 · cited 1×
“For example, juvenile exposure to MPH produces an aversion to cocaine-associated environments in adulthood [”
BackgroundSelf-citationBrandon, C. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00281-0 · Cited by 259
Gerasimov, M. R., Franceschi, M., Volkow, N. D., Gifford, A., Gatley, S. J., Marsteller, D., Molina, P. E., & Dewey, S. L. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38868-8 · Cited by 252
Enduring behavioral effects of early exposure to methylphenidate in rats
Carlezon, W. A., Mague, S. D., & Andersen, S. L. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.020 · Cited by 248
Self-citationPharmacokinetics of methylphenidate in man, rat and monkey.
Wargin, W., Patrick, K., Kilts, C., Gualtieri, C. T., Ellington, K., Mueller, R. A., Kraemer, G., & Breese, G. R. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21542-7 · Cited by 222
Sex differences in the rapid and acute effects of estrogen on striatal D2 dopamine receptor binding
Bazzett, T. J., & Becker, J. B. (1994) · Brain Research · doi:10.1016/0006-8993(94)91229-7 · Cited by 222
Effects of Sex and Estrogen on Behavioral Sensitization to Cocaine in Rats
Hu, M., & Becker, J. B. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-02-00693.2003 · Cited by 209
Badanich, K. A., Adler, K. J., & Kirstein, C. L. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.08.034 · Cited by 203
Volkow, N. D., Wang, G.-J., Fowler, J. S., Fischman, M., Foltin, R., Abumrad, N. N., Gatley, S. J., Logan, J., Wong, C., Gifford, A., et al. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00225-8 · Cited by 184
Russo, S. J., Festa, E. D., Fabian, S. J., Gazi, F. M., Kraish, M., Jenab, S., & Quiñones-Jenab, V (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00317-8 · Cited by 179
Stimulants and the developing brain
Andersen, S. L. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.03.009 · Cited by 168
Self-citationHow to make a rat addicted to cocaine
Roberts, D. C. S., Morgan, D., & Liu, Y. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.028 · Cited by 161
Hyperactives as young adults: Past and current substance abuse and antisocial behavior.
Hechtman, L., Weiss, G., & Perlman, T. (1984) · American Journal of Orthopsychiatry · doi:10.1111/j.1939-0025.1984.tb01507.x · Cited by 154
Srinivas, N. R., Hubbard, J. W., Quinn, D., & Midha, K. K. (1992) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1992.185 · Cited by 120
Dafny, N., & Yang, P. B. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.10.005 · Cited by 114
Vaginal lavage attenuates cocaine-stimulated activity and establishes place preference in rats
Walker, Q. D., Nelson, C. J., Smith, D., & Kuhn, C. M. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00883-3 · Cited by 107
Diurnal differences in sensitization to methylphenidate
Gaytan, O., Yang, P. B., Swann, A. C., & Dafny, N. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02117-x · Cited by 107
Carr, G., Phillips, A. G., & Fibiger, H. C. (1988) · Psychopharmacology · doi:10.1007/bf00176849 · Cited by 105
Achat‐Mendes, C., Anderson, K. L., & Itzhak, Y. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00135-7 · Cited by 97
Methylphenidate and cocaine: the same effects on gene regulation?
YANO, M., & STEINER, H. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.10.004 · Cited by 94
Enhanced behavioral response to repeated-dose cocaine in adolescent rats
Caster, J. M., Walker, Q. D., & Kuhn, C. M. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0159-4 · Cited by 91
Mague, S. D., Andersen, S. L., & Carlezon, W. A. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.037 · Cited by 91
Self-citationCocaine-Induced Rotation: Sex-Dependent Differences Between Left- and Right-Sided Rats
Glick, S. D., Hinds, P. A., & Shapiro, R. M. (1983) · Science · doi:10.1126/science.6879177 · Cited by 85
Crawford, C. A., McDougall, S. A., Meier, T. L., Collins, R. L., & Watson, J. B. (1998) · Psychopharmacology · doi:10.1007/s002130050536 · Cited by 85
Davids, E., Zhang, K., Tarazi, F. I., & Baldessarini, R. J. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0962-5 · Cited by 82
What Do We Know About Drug Addiction?
Volkow, N. D. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1401 · Cited by 82
Pretreatment with methylphenidate sensitizes rats to the reinforcing effects of cocaine
Schenk, S., & Izenwasser, S. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00735-9 · Cited by 76
McDougall, S. A., Collins, R. L., Karper, P. E., Watson, J. B., & Crawford, C. A. (1999) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.7.3.208 · Cited by 73
The role of D1 and D2 receptors in the cocaine conditioned place preference of male and female rats
Nazarian, A., Russo, S. J., Festa, E. D., Kraish, M., & Quiñones-Jenab, V. (2004) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2004.03.004 · Cited by 70
Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine
Izenwasser, S., Coy, A. E., Ladenheim, B., Loeloff, R. J., Cadet, J. L., & French, D. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00274-5 · Cited by 69
Li, Y., Robinson, T. E., & Bhatnagar, S. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03752-6 · Cited by 65
Brenhouse, H. C., & Stellar, J. R. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.09.039 · Cited by 59
Self-citationTorres-Reverón, A., & Dow-Edwards, D. L. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2221-7 · Cited by 59
New methylphenidate formulations for the treatment of attention-deficit/hyperactivity disorder
Patrick, K. S., González, M. A., Straughn, A. B., & Markowitz, J. S. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.1.121 · Cited by 57
Chase, T. D., CARREY, N. J., Soo, E. C., & Wilkinson, M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.10.035 · Cited by 56
Dow-Edwards, D. L., Fico, T. A., Osman, M., Gamagaris, Z., & Hutchings, D. E. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90446-2 · Cited by 55
Teicher, M. H., Polcari, A. M., Foley, M., Valente, E., McGreenery, C. E., Chang, W.-W., McKay, G., & Midha, K. K. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.416 · Cited by 49
Kosofsky, B. E., Genova, L. M., & Hyman, S. E. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903510104 · Cited by 48
Place Conditioning to Study Drug Reward and Aversion
Carlezon, W. A. (2003) · Opioid Research · doi:10.1385/1-59259-379-8:243 · Cited by 48
Ontogeny of behavioral sensitization in the rat: effects of direct and indirect dopamine agonists
McDougall, S. A., Duke, M. A., Bolaños, C. A., & Crawford, C. A. (1994) · Psychopharmacology · doi:10.1007/bf02247482 · Cited by 45
Andersen, S. L., Napierata, L., Brenhouse, H. C., & Sonntag, K. C. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06254.x · Cited by 44
Self-citationJezierski, G., Zehle, S., Bock, J., Braun, K., & Gruss, M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04927.x · Cited by 41
Augustyniak, P. N., Kourrich, S., Rezazadeh, S. M., Stewart, J., & Arvanitogiannis, A. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.09.014 · Cited by 38
Pharmacokinetics and pharmacodynamics of methylphenidate enantiomers in rats
Aoyama, T., Kotaki, H., Sawada, Y., & Iga, T. (1996) · Psychopharmacology · doi:10.1007/bf02805984 · Cited by 37
Leussis, M. P., Brown, R. E., & CARREY, N. J. (2002) · Developmental Psychobiology · doi:10.1002/dev.10059 · Cited by 36
Self-citationGuerriero, R. M., Hayes, M. M., Dhaliwal, S., Ren, J., & Kosofsky, B. E. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.034 · Cited by 36
Melnick, S. M., & Dow-Edwards, D. L. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00545-7 · Cited by 33
Methylphenidate-induced plasticity: what should we be looking for?
Hyman, S. E. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.10.003 · Cited by 22
No time for complacency: The fetal brain on drugs
Kosofsky, B. E., & Hyman, S. E. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1027 · Cited by 20
Dow-Edwards, D. L., & Busidan, Y. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00582-2 · Cited by 18
Research works printed but not linked: 1
- 10.1037%2f1064-1297.7.3.208 · doi:10.1037/1064-1297.7.3.208 · Paper page
Cited by
Sensitive periods of substance abuse: Early risk for the transition to dependence
Jordan, C. J., & Andersen, S. L. (2017) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2016.10.004 · Cited by 455
“Pharmacotherapeutic interventions, such as pre-pubertal methylphenidate exposure, can reduce the rewarding properties of drugs later in life (Adriani et al., 2006a; Andersen et al., 2002a; Brenhouse et al., 2009; Carlezon et al., 2003; Thanos et al., 2007).”
Self-citationBrenhouse, H. C., & Andersen, S. L. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.04.013 · Cited by 343
Self-citationDow-Edwards, D. L., MacMaster, F. P., Peterson, B. S., Niesink, R. J. M., Andersen, S. L., & Braams, B. R. (2019) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2019.106834 · Cited by 173
Self-citationWarren, B. L., Iniguez, S. D., Alcantara, L. F., Wright, K. N., Parise, E. M., Weakley, S. K., & Bolanos-Guzman, C. A. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1470-11.2011 · Cited by 81
Juvenile methylphenidate reduces prefrontal cortex plasticity via D3 receptor and BDNF in adulthood
Andersen, S. L., & Sonntag, K. C. (2014) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2014.00001 · Cited by 58
Self-citation
Metadata
- Authors
- Brenhouse, H. C., Napierata, L., Kussmaul, L., Leussis, M., & Andersen, S. L.
- Affiliations
- Harvard University (US)
- Venue
- Developmental Neuroscience
- Publisher
- S. Karger AG
- Published
- 2009
- Volume
- 31
- Issue
- 1-2
- Pages
- 95-106
- ISSN
- 0378-5866 (ISSN-L)
- 1421-9859
- PMC
- PMC5268706
- OpenAlex
- W2038307513
- Cited by
- 24
- References
- 73
- Citations by year
- 2022: 1 · 2020: 1 · 2019: 2 · 2018: 2 · 2016: 2 · 2015: 1 · 2014: 2 · 2013: 3 · 2012: 3
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Developmental Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (R01MH091114)
- National Institute on Drug Abuse (DA 015403, R01DA026485, R01DA015403)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- methylphenidate, incentive processing, sex differences, route of administration, adolescent rats, long-term drug effects, psychostimulants
- MeSH terms
- Administration, Oral, Aging, Central Nervous System Stimulants, Animals, Conditioning, Operant, Female, Injections, Intraperitoneal, Male, Methylphenidate, Motivation, Motor Activity, Sex Characteristics, Stereoisomerism, Rats, Sprague-Dawley, Substance-Related Disorders, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.